$95.26-1.95% · 3M
Moving avg
1W-0.46%
1M-10.06%
3M-0.66%
6M+21.38%
YTD+18.88%
1Y+42.75%
3Y+28.14%
5Y+11.56%
52-week range
$58.9970% of range$110.68
Company health
Value3/6
Growth2/6
Profitability3/6
Health1/6
Dividend3/6
Bull vs bear
Strengths
- Analyst consensus is "Buy"
- High return on equity (387%)
- Revenue compounding 10% a year
Risks
- Richly valued at 46.6x earnings
Key statistics
Valuation
Market cap
$121.55B
Enterprise value
$206.27B
P/E ratio (TTM)
46.64x
P/S ratio (TTM)
0.34x
EV/EBITDA
18.53x
Per share & returns
EPS (TTM)
$2.30
Dividend yield
2.47%
Beta (1Y)
0.60
30-day change
-10.06%
Trading
Volume (24h)
1.97M
Previous close
$94.72
Shares outstanding
1.28B
About CVS Health Corp.
Sector
Healthcare
Industry
Medical - Healthcare Plans
Exchange
NYSE
Symbol
CVS
CVS Health Corp. is a large-cap healthcare company in the Medical - Healthcare Plans industry. Its shares are listed on NYSE (United States) and trade under the ticker CVS.
Frequently asked questions
What is CVS Health Corp.'s market cap?
CVS Health Corp. (CVS) has a market capitalization of $121.55B.
What is CVS Health Corp.'s P/E ratio?
CVS Health Corp. trades at a price-to-earnings (P/E) ratio of 46.64.
What exchange does CVS trade on?
CVS trades on NYSE.
Appears in
Compare & explore
Eli Lilly and CompanyLLY
$1,216.03-0.35%
$1.15T cap
Johnson & JohnsonJNJ
$261.33+0.18%
$629.78B cap
AbbVie Inc.ABBV
$250.78+0.81%
$443.08B cap
UnitedHealth Group IncorporatedUNH
$402.12-0.86%
$365.18B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$354.73B cap
Merck & Co., Inc.MRK
$134.53+1.21%
$332.26B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.30B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.01B cap